GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Itonis Inc (OTCPK:ITNS) » Definitions » EBIT

Itonis (Itonis) EBIT : $-1.55 Mil (TTM As of Feb. 2008)


View and export this data going back to 2007. Start your Free Trial

What is Itonis EBIT?

Itonis's earnings before interest and taxes (EBIT) for the three months ended in Feb. 2008 was $-0.42 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Feb. 2008 was $-1.55 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Itonis's annualized ROC % for the quarter that ended in Feb. 2008 was -235.10%. Itonis's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2008 was -8,778.95%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Itonis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2008 was -255.17%.


Itonis EBIT Historical Data

The historical data trend for Itonis's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Itonis EBIT Chart

Itonis Annual Data
Trend Nov05 Nov06 Nov07
EBIT
-0.12 -2.34 -1.32

Itonis Quarterly Data
Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.19 -0.36 -0.26 -0.52 -0.42

Competitive Comparison of Itonis's EBIT

For the Medical Distribution subindustry, Itonis's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Itonis's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Itonis's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Itonis's EV-to-EBIT falls into.



Itonis EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Itonis  (OTCPK:ITNS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Itonis's annualized ROC % for the quarter that ended in Feb. 2008 is calculated as:

ROC % (Q: Feb. 2008 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Nov. 2007 ) + Invested Capital (Q: Feb. 2008 ))/ count )
=-1.668 * ( 1 - % )/( (0.229 + 1.19)/ 2 )
=-1.668/0.7095
=-235.10 %

where

Note: The Operating Income data used here is four times the quarterly (Feb. 2008) data.

2. Joel Greenblatt's definition of Return on Capital:

Itonis's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2008 is calculated as:

ROC (Joel Greenblatt) %(Q: Feb. 2008 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2007  Q: Feb. 2008
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1.668/( ( (0.02 + max(-1.105, 0)) + (0.018 + max(-1.024, 0)) )/ 2 )
=-1.668/( ( 0.02 + 0.018 )/ 2 )
=-1.668/0.019
=-8,778.95 %

where Working Capital is:

Working Capital(Q: Nov. 2007 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.001) - (0.897 + 0 + 0.209)
=-1.105

Working Capital(Q: Feb. 2008 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.003 + 0 + 0.15) - (0.812 + 0 + 0.365)
=-1.024

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Feb. 2008) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Itonis's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Feb. 2008 )
=-1.554/0.609
=-255.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Itonis EBIT Related Terms

Thank you for viewing the detailed overview of Itonis's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Itonis (Itonis) Business Description

Traded in Other Exchanges
N/A
Address
22600-C Lambert Street, Suite 902, Lake Forest, CA, USA, 92630
Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.

Itonis (Itonis) Headlines